Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma

Br J Haematol. 2018 May;181(4):539-542. doi: 10.1111/bjh.14634. Epub 2017 Apr 3.
No abstract available

Keywords: CC chemokine receptor 4; adult T-cell leukaemia-lymphoma; cutaneous adverse reaction; mogamulizumab; prognostic factor.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal, Humanized* / administration & dosage
  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Disease-Free Survival
  • Female
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell* / drug therapy
  • Leukemia-Lymphoma, Adult T-Cell* / mortality
  • Male
  • Middle Aged
  • Skin Diseases* / chemically induced
  • Skin Diseases* / mortality
  • Survival Rate

Substances

  • Antibodies, Monoclonal, Humanized
  • mogamulizumab